Lantheus to redeem portion of 9¾% notes with proceeds from stock sale

By Marisa Wong

Madison, Wis., June 24 – Lantheus Holdings, Inc. plans to redeem a portion of its outstanding 9¾% senior notes due 2017 using proceeds from an offering of common stock, according to an S-1 filing with the Securities and Exchange Commission.

The company plans to use the remaining proceeds of its $125 million offering for general corporate purposes.

Based in North Billerica, Mass., Lantheus develops, manufactures, sells and distributes innovative diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.